Geometry Global

Geometry is a computational biotechnology company focused on transforming drug discovery through the application of geometric deep learning and structural biology. The company's platform leverages the 3D geometric structures of biological molecules to identify novel binding sites and design small molecules with high precision. By integrating advanced mathematics with high-throughput experimental data, Geometry aims to accelerate the development of therapeutics for challenging, previously undruggable targets. The company is currently in the pre-clinical stage, focusing on building its internal pipeline and establishing strategic partnerships in oncology and immunology.